Home›Research›Compare›Cagrilintide vs Oxyntomodulin
Peptide Comparison
Cagrilintide vs Oxyntomodulin
Both are Fat Loss peptides.
Cagrilintide
AM833
Half-life: ~7 days
13 providers listed
Quick Verdict
Cagrilintide
Risk
Half-life
~7 days
Oxyntomodulin
Risk
Half-life
—
Side-by-Side Comparison
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
A once-weekly long-acting amylin analogue in late-stage development. Showing impressive weight loss (~15%) in trials, especially when combined with semaglutide (CagriSema).
Research Areas
About Oxyntomodulin
Dual GLP-1/glucagon receptor agonist. GLP-1 component suppresses appetite; glucagon component increases energy expenditure and fatty acid oxidation. Net effect is reduced caloric intake and elevated metabolic rate.
An endogenous peptide produced in the gut that activates both GLP-1 and glucagon receptors. Dual receptor activation produces appetite suppression plus increased energy expenditure — a combination not achievable with GLP-1 agonists alone.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Cagrilintide
13 listed
Browse directory →
Providers offering
Oxyntomodulin
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.